Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study concludes
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
oncnursingnews4d
Topical Drug Combos May Be Beneficial for CIPN
Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect for patients undergoing cancer treatments, and ...
Neuropathy is becoming a bigger problem for more people than ever before
If you’re suffering from stabbing pain, numbness, tingling or a burning sensation in your arms, legs, hands or feet, you may ...
Bexion Pharmaceuticals, Inc. Awarded Grant from The Michael J. Fox Foundation to Advance BXQ-350
Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...
KELOLAND News9d
Dynamic Spine & Neuropathy releases new book
Dr. Jeff Watson, with Dynamic Spine and Neuropathy in Sioux Falls, is a leading expert in the field of chiropractics. He recently released a groundbreaking new book titled “A Patient’s ...
PSRI Hospital: Leading the Way in Specialized Diabetic Foot Care in Delhi NCR
Leading the Way in Specialized Diabetic Foot Care in Delhi NCRDelhi, India - November 17, 2024 — Diabetes, often called the ...
Yahoo Finance4d
Bexion Pharmaceuticals, Inc. to Participate in the Jefferies London Healthcare Conference
is advancing a new class of biologic therapy aimed at treating solid tumors and chemotherapy-induced peripheral neuropathy (CIPN), with the potential to expand its portfolio into additional cancer ...
ots10d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...